Zeta Corporation's PRAME 7mL is a cutting-edge solution for studying tumor growth mechanisms in cancer research. This high-quality product offers researchers a powerful tool to investigate the role of PRAME in cancer progression.

Key Benefits:

Precise analysis of transcriptional repression
Insight into retinoic acid signaling inhibition
Enhanced understanding of tumor growth promotion
Facilitates research on melanoma-specific antigens

PRAME (Preferentially Expressed Antigen in Melanoma) acts as a transcriptional repressor, inhibiting retinoic acid signaling through RARA and RARG receptors. PRAME promotes tumor growth by preventing retinoic acid-induced cell proliferation arrest, making it a crucial subject for oncology research.

This gene encodes an antigen predominantly expressed in human melanomas and recognized by cytolytic T lymphocytes. Its unique expression pattern, absent in most normal tissues except for the testis, makes PRAME an ideal target for cancer research and potential therapeutic development.

Applications:

Melanoma research
Cancer cell growth studies
Immunotherapy development
Transcriptional regulation analysis

Zeta Corporation's PRAME 7mL provides researchers with a reliable and consistent product for investigating alternative splicing and multiple transcript variants. This advanced solution enables in-depth studies of how PRAME gives cancer cells a growth advantage.

Researchers can also utilize Recombinant PRAME antibodies for IHC for immunohistochemistry applications, which ensures accurate detection and localization of PRAME expression in tissue samples. Additionally, the PRAME antibody clone ZR383 offers high specificity for PRAME-related studies, facilitating precise analysis in oncology research.

With Zeta Corporation immunohistochemistry reagents, you can achieve consistent, reproducible results essential for advancing cancer research and potential clinical applications.

Elevate your research today. Order Zeta Corporation® PRAME 7mL now and unlock new insights into cancer biology.

Buy More, Save More.